Back to top
Top
U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Severe Obstetric Complications

Compare Versions of: "Severe Obstetric Complications"

The Compare function compares two years of the measure specifications found in the header of the measure's HTML. It does not include a comparison of any information in the body of the HTML, e.g., population criteria, Clinical Quality Language, or value sets.

Strikethrough text highlighted in red indicates information changed from the previous version. Text highlighted in green indicates information updated in the new eCQM version.

Compare version to

Measure Information 2023 Reporting Period 2024 Reporting Period 2025 Reporting Period
Title Severe Obstetric Complications Severe Obstetric Complications Severe Obstetric Complications
CMS eCQM ID CMS1028v1 CMS1028v2 CMS1028v3
Short Name

PC-07

PC-07

PC-07

CBE ID* Not Applicable Not Applicable Not Applicable
Measure Steward The Joint Commission The Joint Commission The Joint Commission
Description

Patients with severe obstetric complications which occur during the inpatient delivery hospitalization.

Patients with severe obstetric complications which occur during the inpatient delivery hospitalization

Patients with severe obstetric complications that occur during the inpatient delivery hospitalization

Measure Scoring Proportion measure Proportion measure Proportion measure
Measure Type Outcome Outcome Outcome
Stratification *See CMS1028v1.html

Stratum1: Delivery hospitalizations with severe obstetric complications excluding hospitalizations where transfusion was the only severe obstetric complication.

Additionally, this measure will be stratified by race and ethnicity after measure submission.

This measure will be stratified by race/ethnicity and payer after measure submission

Risk Adjustment *See CMS1028v1.html

The Severe Obstetric Complications Risk Adjustment Methodology Report is available on the eCQI Resource Center (https://ecqi.healthit.gov).

Pre-existing conditions and variables must be present on admission. Please note that present on admission codes may be those entered by coding staff, extracted from billing/claims data.

- Anemia

- Asthma

- Autoimmune Disease

- Bariatric Surgery

- Bleeding disorder

- Cardiac Disease

- Gastrointestinal Disease

- Gestational Diabetes

- HIV

- Housing Instability

- Hypertension

- Maternal Age (derived from birthdate)

- Mental Health Disorder

- Morbid Obesity

- Multiple Pregnancy

- Neuromuscular Disease

- Other Pre-eclampsia

- Placenta Previa

- Placental Abruption

- Placental Accreta Spectrum

- Pre-existing Diabetes

- Preterm Birth

- Previous Cesarean

- Pulmonary Hypertension

- Renal Disease

- Severe Pre-eclampsia

- Substance Abuse

- Thyrotoxicosis

- Long-term Anticoagulant Use

- Obstetric VTE

Lab and Physical Exam Results:

Report the first resulted value 24 hours prior to start of encounter and before time of delivery in UCUM units specified:

- Heart rate: {beats}/min

- Systolic blood pressure: mm[Hg]

- White blood cell count: 10*3/uL

- Hematocrit: %

Note regarding submission of risk variable data: The risk variable definitions are included in the specifications and risk variable data should be sent with eCQM data in the QRDA1 file. Specific risk variable templates are not needed in the QRDA1 files.

The Severe Obstetric Complications Risk Adjustment Methodology Report is available on the eCQI Resource Center (https://ecqi.healthit.gov).

Pre-existing conditions and variables must be present on admission. Please note that present on admission codes may be extracted from billing/claims data that was entered by coding staff (Leonard, Kennedy, Carmichael, Lyell, & Main, 2020; Main, Leonard, & Menard, 2020).

- Anemia (includes sickle cell disease)

- Asthma

- Autoimmune Disease

- Bariatric Surgery

- Bleeding Disorder

- Cardiac Disease

- Economic Housing Instability

- Gastrointestinal Disease

- Gestational Diabetes

- HIV

- Hypertension

- Long-term Anticoagulant Use

- Maternal Age (derived from birthdate)

- Mental Health Disorder

- Morbid Obesity

- Multiple Pregnancy

- Neuromuscular Disease

- Obstetric VTE

- Other Pre-eclampsia

- Placenta Previa

- Placental Abruption

- Placental Accreta Spectrum

- Pre-existing Diabetes

- Preterm Birth

- Previous Cesarean

- Pulmonary Hypertension

- Renal Disease

- Severe Pre-eclampsia

- Substance Abuse

- Thyrotoxicosis

Lab and Physical Exam Results:

Report the first resulted value 24 hours prior to start of encounter and before time of delivery in UCUM units specified:

- Heart rate: {beats}/min

- Systolic blood pressure: mm[Hg]

- Hematocrit: %

- White blood cell count: 10*3/uL

Note regarding submission of risk variable data: The risk variable definitions are included in the specifications and risk variable data should be sent with eCQM data in the QRDA1 file. Specific risk variable templates are not needed in the QRDA1 files.

Rationale *See CMS1028v1.html

The United States (US) experiences higher rates of maternal morbidity and mortality than most other developed countries. These rates have continued to trend upward in recent decades (CDC, n.d.). Research indicates that the overall rate of severe maternal morbidity (SMM) increased by almost 200% between 1993 and 2014 to 144 per 10,000 delivery hospitalizations (CDC, n.d.), with more than 25,000 women per year experiencing obstetric complications (U.S. Department of Health and Human Services, 2020). Recent maternal mortality data from 2018 reveal that 658 women in the US died from maternal causes, resulting in a rate of 17.4 deaths per 100,000 live births, with 77% of the deaths attributed to direct obstetric causes like hemorrhage, preeclampsia, obstetric embolism, and other complications (Hoyert & Minino, 2018). 144 per 10,000 women hospitalized for delivery have experienced SMM, including hemorrhage, embolism, hypertension, stroke, and other serious complications (CDC,2020). Racial and ethnic disparities for Black women and Hispanic women are at a significantly higher risk for developing these complications than are Non-Hispanic White women (Leonard et al., 2019). Increasing rates of SMM are resulting in increased healthcare costs, longer hospitalization stays and impacts on a woman's health.

There is limited national evaluation of hospitals' performance on maternal morbidity and mortality although SMM is widely used at the population level. SMM is linked to maternal mortality, varies significantly among hospitals, and has significant racial/ethnic and urban/rural disparities. SMM is a cost driver for both Medicaid and commercial plans. This measure is important as it will assist in the discovery and understanding of SMM patterns which can lead to improvements in the safety and quality of maternal care necessary to reduce SMM rates.

The United States (US) experiences higher rates of maternal morbidity and mortality than most other developed countries. These rates have continued to trend upward in recent decades (CDC, 2021). Research indicates that the overall rate of severe maternal morbidity (SMM) increased by almost 200% between 1993 and 2014 to 144 per 10,000 delivery hospitalizations (CDC, 2021), with more than 25,000 women per year experiencing obstetric complications (U.S. Department of Health and Human Services, 2020). Recent maternal mortality data from 2018 reveal that 658 women in the US died from maternal causes, resulting in a rate of 17.4 deaths per 100,000 live births, with 77% of the deaths attributed to direct obstetric causes like hemorrhage, preeclampsia, obstetric embolism, and other complications (Hoyert & Minino, 2018). 144 per 10,000 women hospitalized for delivery have experienced SMM, including hemorrhage, embolism, hypertension, stroke, and other serious complications (CDC, 2021). Racial and ethnic disparities exist: Black women and Hispanic women are at a significantly higher risk for developing these complications than are Non-Hispanic White women (Leonard, Main, Scott, Profit, & Carmichael, 2019). Increasing rates of SMM are resulting in increased healthcare costs, longer hospitalization stays and impacts on a woman's health (Callaghan, Creanga, & Kuklina, 2012).

There is limited national evaluation of hospitals' performance on maternal morbidity and mortality although SMM is widely used at the population level. SMM is linked to maternal mortality, varies significantly among hospitals, and has significant racial/ethnic and urban/rural disparities. SMM is a cost driver for both Medicaid and commercial plans. This measure is important as it will assist in the discovery and understanding of SMM patterns that can lead to improvements in the safety and quality of maternal care necessary to reduce SMM rates.

Clinical Recommendation Statement *See CMS1028v1.html

Healthy People 2030 Measure (MICH-05): Reduce severe maternal complications identified during delivery hospitalizations

The American College of Obstetricians and Gynecologists (the College) and the Society for Maternal-Fetal Medicine (SMFM) recommend identifying potential cases of severe maternal morbidity for further review, with a focus on outcomes and complications, and consider this an important step toward promoting safe obstetric care.

Healthy People 2030 Measure (MICH-05): Reduce severe maternal complications identified during delivery hospitalizations (U.S. Department of Health and Human Services, n.d.).

The American College of Obstetricians and Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine recommend identifying potential cases of severe maternal morbidity for further review, with a focus on outcomes and complications, and consider this an important step toward promoting safe obstetric care (American College of Obstetricians and Gynecologists and the Society for Maternal–Fetal Medicine, Kilpatrick, & Ecker, 2016).

Improvement Notation

Improvement noted as a decrease in the rate.

Improvement noted as a decrease in the rate

Improvement noted as a decrease in the rate

Definition *See CMS1028v1.html

For this measure, specifications are modeled after the nationally available and adopted CDC definition for Severe Maternal Morbidity (SMM) with the addition of maternal mortality. At times, we may refer to the CDC indicators of morbidity as SMM, but the outcome of the measure, which includes morbidity and mortality, is referred to as Severe Obstetric Complications (SOC).

For this measure, specifications are modeled after the nationally available and adopted CDC definition for Severe Maternal Morbidity (SMM) with the addition of maternal mortality. At times, we may refer to the CDC indicators of morbidity as SMM, but the outcome of the measure, which includes morbidity and mortality, is referred to as Severe Obstetric Complications (SOC).

Guidance

In the case of multiple births, map the first delivery date/time (Baby A) as the delivery date/time for the encounter.

This measure allows for 2 approaches to determine estimated gestational age (EGA) in the following order of precedence:

1. The EGA is calculated using the American College of Obstetricians and Gynecologists ReVITALize guidelines.*

2. The EGA is obtained from a discrete field in the electronic health record. This option is only used when the calculated EGA is not available.

Wherever gestational age is mentioned, relative to the delivery, the intent is to capture the last estimated gestational age prior to or at the time of delivery.

 

*ACOG ReVITALize Guidelines for Calculating Gestational Age:

 

Gestational Age = (280-(EDD minus Reference Date))/7

--Estimated Due Date (EDD): The best obstetrical Estimated Due Date is determined by last menstrual period if confirmed by early ultrasound or no ultrasound performed, or early ultrasound if no known last menstrual period or the ultrasound is not consistent with last menstrual period, or known date of fertilization (eg, assisted reproductive technology)

--Reference Date is the date on which you are trying to determine gestational age. For purposes of this eCQM, Reference Date would be the Date of Delivery.

Note however the calculation may yield a non-whole number and gestational age should be rounded off to the nearest completed week. For example, an infant born on the 5th day of the 36th week (35 weeks and 5/7 days) is at a gestational age of 35 weeks, not 36 weeks.

This eCQM is an episode-based measure. An episode is defined as each inpatient hospitalization or encounter that ends during the measurement period.

This version of the eCQM uses QDM version 5.6. Please refer to the QDM page for more information on the QDM.

In the case of multiple births, map the first delivery date/time (Baby A) as the delivery date/time for the encounter.

This measure allows for 3 approaches to determine gestational age (GA) in the following order of precedence:

1. The GA is calculated using the American College of Obstetricians and Gynecologists ReVITALize guidelines.*

2. The GA is obtained from a discrete field in the electronic health record. This option is only used when the calculated GA is not available.

3. The GA is based on ICD10 or SNOMED codes indicative of weeks gestation. This option is only used when results from items #1 and #2 (see above) are not available.

Wherever gestational age is mentioned, relative to the delivery, the intent is to capture the last estimated gestational age prior to or at the time of delivery.

 

*ACOG ReVITALize Guidelines for Calculating Gestational Age:

 

Gestational Age = (280-(Estimated Due Date minus Reference Date))/7

--Estimated Due Date (EDD): The best obstetrical EDD is determined by last menstrual period if confirmed by early ultrasound or no ultrasound performed, or early ultrasound if no known last menstrual period or the ultrasound is not consistent with last menstrual period, or known date of fertilization (e.g., assisted reproductive technology)

--Reference Date is the date on which you are trying to determine gestational age. For purposes of this eCQM, Reference Date would be the Date of Delivery.

Note however the calculation may yield a non-whole number and gestational age should be rounded off to the nearest completed week. For example, an infant born on the 5th day of the 36th week (35 weeks and 5/7 days) is at a gestational age of 35 weeks, not 36 weeks.

This eCQM is an episode-based measure. An episode is defined as each inpatient hospitalization or encounter that ends during the measurement period.

This version of the eCQM uses QDM version 5.6. Please refer to the QDM page for more information on the QDM.

In the case of multiple births, map the first delivery date/time (Baby A) as the delivery date/time for the encounter.

This measure allows for 3 approaches to determine gestational age (GA) in the following order of precedence:

1. The GA is calculated using the American College of Obstetricians and Gynecologists ReVITALize guidelines.*

2. The GA is obtained from a discrete field in the electronic health record. This option is only used when the calculated GA is not available.

3. The GA is based on ICD10 or SNOMED codes indicative of weeks gestation. This option is only used when results from items #1 and #2 (see above) are not available.

Wherever gestational age is mentioned, relative to the delivery, the intent is to capture the last estimated gestational age prior to or at the time of delivery.

 

*ACOG ReVITALize Guidelines for Calculating Gestational Age (ACOG, 2014):

 

Gestational Age = (280-(Estimated Due Date minus Reference Date))/7

--Estimated Due Date (EDD): The best obstetrical EDD is determined by last menstrual period if confirmed by early ultrasound or no ultrasound performed, or early ultrasound if no known last menstrual period or the ultrasound is not consistent with last menstrual period, or known date of fertilization (e.g., assisted reproductive technology)

--Reference Date is the date on which you are trying to determine gestational age. For purposes of this eCQM, Reference Date would be the Date of Delivery.

Note however the calculation may yield a non-whole number and gestational age should be rounded down to the nearest completed week. For example, an infant born on the 5th day of the 36th week (35 weeks and 5/7 days) is at a gestational age of 35 weeks, not 36 weeks.

This eCQM is an episode-based measure. An episode is defined as each inpatient hospitalization or encounter that ends during the measurement period.

This version of the eCQM uses QDM version 5.6. Please refer to the QDM page for more information on the QDM.

Initial Population

Inpatient hospitalizations for patients age >= 8 years and < 65 admitted to the hospital for inpatient acute care who undergo a delivery procedure with a discharge date that ends during the measurement period

Inpatient hospitalizations for patients age >= 8 years and < 65 admitted to the hospital for inpatient acute care who undergo a delivery procedure with a discharge date that ends during the measurement period

Inpatient hospitalizations for patients age >= 8 years and < 65 admitted to the hospital for inpatient acute care who undergo a delivery procedure with a discharge date that ends during the measurement period

Denominator

Inpatient hospitalizations for patients delivering stillborn or live birth with >= 20 weeks, 0 days gestation completed

Inpatient hospitalizations for patients delivering stillborn or live birth with >= 20 weeks, 0 days gestation completed

Inpatient hospitalizations for patients delivering stillborn or live birth with >= 20 weeks, 0 days gestation completed

Denominator Exclusions

Inpatient hospitalizations for patients with confirmed diagnosis of COVID with COVID-related respiratory condition or patients with confirmed diagnosis of COVID with COVID-related respiratory procedure

Inpatient hospitalizations for patients with confirmed diagnosis of COVID with COVID-related respiratory condition or patients with confirmed diagnosis of COVID with COVID-related respiratory procedure

Inpatient hospitalizations for patients with confirmed diagnosis of COVID with COVID-related respiratory condition or patients with confirmed diagnosis of COVID with COVID-related respiratory procedure during the encounter

Numerator

Inpatient hospitalizations for patients with severe obstetric complications (not present on admission that occur during the current delivery encounter) including the following:

- Severe maternal morbidity diagnoses (see list below)

- Severe maternal morbidity procedures (see list below)

- Discharge disposition of expired

Severe Maternal Morbidity Diagnoses:

- Cardiac

Acute heart failure

Acute myocardial infarction

Aortic aneurysm

Cardiac arrest/ventricular fibrillation

Heart failure/arrest during procedure or surgery

- Hemorrhage

Disseminated intravascular coagulation

Shock

- Renal

Acute renal failure

- Respiratory

Adult respiratory distress syndrome

Pulmonary edema

- Sepsis

- Other OB

Air and thrombotic embolism

Amniotic fluid embolism

Eclampsia

Severe anesthesia complications

- Other Medical

Puerperal cerebrovascular disorder

Sickle cell disease with crisis

Severe Maternal Morbidity Procedures:

- Blood transfusion

- Conversion of cardiac rhythm

- Hysterectomy

- Temporary tracheostomy

- Ventilation

Inpatient hospitalizations for patients with severe obstetric complications (not present on admission that occur during the current delivery encounter) including the following:

- Severe maternal morbidity diagnoses (see list below)

- Severe maternal morbidity procedures (see list below)

- Discharge disposition of expired

Please note that present on admission codes may be those entered by coding staff, extracted from billing/claims data.

Severe Maternal Morbidity Diagnoses:

- Cardiac

Acute heart failure

Acute myocardial infarction

Aortic aneurysm

Cardiac arrest/ventricular fibrillation

Heart failure/arrest during procedure or surgery

- Hemorrhage

Disseminated intravascular coagulation

Shock

- Renal

Acute renal failure

- Respiratory

Adult respiratory distress syndrome

Pulmonary edema

- Sepsis

- Other OB

Air and thrombotic embolism

Amniotic fluid embolism

Eclampsia

Severe anesthesia complications

- Other Medical

Puerperal cerebrovascular disorder

Sickle cell disease with crisis

Severe Maternal Morbidity Procedures:

- Blood transfusion

- Conversion of cardiac rhythm

- Hysterectomy

- Temporary tracheostomy

- Ventilation

Two numerator populations are defined for this measure:

1. All Severe Obstetric Complications (SOC).

2. SOC excluding encounters where transfusion was the only SOC.

Inpatient hospitalizations for patients with severe obstetric complications (not present on admission that occur during the current delivery encounter) including the following:

- Severe maternal morbidity diagnoses (see list below)

- Severe maternal morbidity procedures (see list below)

- Discharge disposition of expired

Please note that present on admission codes may be extracted from billing/claims data that was entered by coding staff.

Severe Maternal Morbidity Diagnoses:

- Cardiac

Acute heart failure

Acute myocardial infarction

Aortic aneurysm

Cardiac arrest/ventricular fibrillation

Heart failure/arrest during procedure or surgery

- Hemorrhage

Disseminated intravascular coagulation

Shock

- Renal

Acute renal failure

- Respiratory

Adult respiratory distress syndrome

Pulmonary edema

- Sepsis

- Other OB

Air and thrombotic embolism

Amniotic fluid embolism

Eclampsia

Severe anesthesia complications

- Other Medical

Puerperal cerebrovascular disorder

Sickle cell disease with crisis

Severe Maternal Morbidity Procedures:

- Blood transfusion

- Conversion of cardiac rhythm

- Hysterectomy

- Temporary tracheostomy

- Ventilation

Numerator Exclusions

Not applicable

Not applicable

Inpatient hospitalizations with blood transfusion or hysterectomy with a diagnosis of placenta percreta or placenta increta and no additional severe obstetrical complications.

Denominator Exceptions

None

None

None

Next Version No Version Available
Previous Version No Version Available
Specifications
Attachment Size
CMS1028v2.html 180.07 KB
CMS1028v2.zip 139.63 KB
CMS1028v2-TRN.xlsx 23.22 KB
CMS1028v2-eCQMFlow.pdf 195.49 KB

This is a risk adjusted measure. Risk Adjustment Methodology Report: Severe Obstetric Complications Methodology Report

There is a known issue on CMS1028v2. See issue EKI-23 on the ONC eCQM Known Issues Dashboard for details.

eCQM Jira Issue Tracker
*Note there may be more tickets in the eCQM Tracker - ONC Project Tracking System (Jira) for this measure. Only tickets tagged with their associated CMS measure ID appear.

Header

  • Updated grammar, wording, and/or formatting to improve readability and consistency.

    Measure Section: Description

    Source of Change: Annual Update

  • Updated copyright.

    Measure Section: Copyright

    Source of Change: Annual Update

  • Added link to the Risk Methodology Report to aid implementation.

    Measure Section: Risk Adjustment

    Source of Change: Measure Lead

  • Clarified Lab and Physical Exam Results to improve readability.

    Measure Section: Risk Adjustment

    Source of Change: Measure Lead

  • Updated risk adjustment variable description from 'BMI>=40' to 'Morbid Obesity' as ICD-10 coding guidelines indicate BMI codes are not to be assigned for pregnant patients.

    Measure Section: Risk Adjustment

    Source of Change: Measure Lead

  • Added guidance to clarify patients may now be qualified for the denominator based on gestational age diagnosis codes when neither calculated or reported gestational age is available.

    Measure Section: Guidance

    Source of Change: Measure Lead

  • Added guidance to clarify where present on admission information may be sourced.

    Measure Section: Multiple Sections

    Source of Change: Measure Lead

Logic

  • Added logic to denominator criteria to capture patients with specified weeks gestation based on diagnosis codes when neither calculated or reported gestational age is available.

    Measure Section: Denominator

    Source of Change: Measure Lead

  • Updated definition name to 'Risk Variable Morbid Obesity' to reflect change in value set as ICD-10 coding guidelines indicate BMI codes are not to be assigned for pregnant patients.

    Measure Section: Definitions

    Source of Change: Measure Lead

  • Updated the names of CQL definitions, functions, and/or aliases for clarification and to align with the CQL Style Guide.

    Measure Section: Definitions

    Source of Change: Standards/Technical Update

  • Updated the version number of the PC Maternal Library to v3.0.000.

    Measure Section: Definitions

    Source of Change: Annual Update

  • Removed 'Truncate.Time' function and added 'as DateTime' to Estimated Delivery Date result to simplify logic and allow hospitals to submit data as date only or as date/time.

    Measure Section: Functions

    Source of Change: Measure Lead

  • Updated the version number of the PC Maternal Library to v3.0.000.

    Measure Section: Functions

    Source of Change: Annual Update

Value Set

The VSAC is the source of truth for the value set content, please visit the VSAC for downloads of current value sets.

  • Added value set 20 to 42 Plus Weeks Gestation (2.16.840.1.113762.1.4.1110.67) based on change in measure requirements/measure specification.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set (2.16.840.1.113883.3.117.1.7.1.271): Renamed to Acute or Persistent Asthma based on recommended value set naming conventions.

    Measure Section: Terminology

    Source of Change: Annual Update

  • Value set Anemia (2.16.840.1.113762.1.4.1029.323): Added 4 ICD-10-CM codes (D59.30, D59.31, D59.32, D59.39) based on terminology update. Deleted 1 ICD-10-CM code (D59.3) based on terminology update.

    Measure Section: Terminology

    Source of Change: Annual Update

  • Value set Bleeding Disorder (2.16.840.1.113762.1.4.1029.287): Added 10 ICD-10-CM codes (D68.00, D68.01, D68.020, D68.021, D68.022, D68.023, D68.029, D68.03, D68.04, D68.09) based on terminology update. Deleted 1 ICD-10-CM code (D68.0) based on terminology update.

    Measure Section: Terminology

    Source of Change: Annual Update

  • Value set Blood Transfusion (2.16.840.1.113762.1.4.1029.213): Added 19 SNOMED CT codes based on terminology update. Added 20 ICD-10-PCS codes based on terminology update.

    Measure Section: Terminology

    Source of Change: Annual Update

  • Value set Cardiac Disease (2.16.840.1.113762.1.4.1029.341): Added 30 ICD-10-CM codes based on terminology update. Deleted 5 ICD-10-CM codes (I47.2, I31.3, I34.8, Q21.1, Q21.2) based on terminology update.

    Measure Section: Terminology

    Source of Change: Annual Update

  • Value set Economic Housing Instability (2.16.840.1.113762.1.4.1029.292): Added 3 ICD-10-CM codes (Z59.82, Z59.86, Z59.87) based on terminology update.

    Measure Section: Terminology

    Source of Change: Annual Update

  • Value set Gastrointestinal Disease (2.16.840.1.113762.1.4.1029.338): Added 1 ICD-10-CM code (K76.82) based on terminology update.

    Measure Section: Terminology

    Source of Change: Annual Update

  • Value set Hematocrit lab test (2.16.840.1.113762.1.4.1045.114): Added 1 LOINC code (48703-3) based on review by technical experts, SMEs, and/or public feedback.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set (2.16.840.1.113762.1.4.1029.272): Renamed to HIV in Pregnancy Childbirth and Puerperium based on recommended value set naming conventions.

    Measure Section: Terminology

    Source of Change: Annual Update

  • Value set Mental Health Disorder (2.16.840.1.113762.1.4.1029.314): Added 5 ICD-10-CM codes (F32.A, F06.70, F06.71, F43.81, F43.89) based on terminology update. Deleted 1 ICD-10-CM code (F43.8) based on terminology update.

    Measure Section: Terminology

    Source of Change: Annual Update

  • Value set (2.16.840.1.113762.1.4.1029.329): Renamed to Mild or Moderate Preeclampsia based on recommended value set naming conventions.

    Measure Section: Terminology

    Source of Change: Annual Update

  • Value set (2.16.840.1.113762.1.4.1029.290): Renamed to Morbid or Severe Obesity based on recommended value set naming conventions.

    Measure Section: Terminology

    Source of Change: Annual Update

  • Value set Neuromuscular Disease (2.16.840.1.113762.1.4.1029.308): Added 2 ICD-10-CM codes (G40.833, G40.834) based on terminology update.

    Measure Section: Terminology

    Source of Change: Annual Update

  • Value set Payer (2.16.840.1.114222.4.11.3591): Added 5 SOP codes (1111, 1112, 142, 344, 141) based on review by technical experts, SMEs, and/or public feedback.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Previous Cesarean (2.16.840.1.113762.1.4.1029.278): Added 1 ICD-10-CM code (O34.218) based on terminology update.

    Measure Section: Terminology

    Source of Change: Annual Update

  • Value set Renal Disease (2.16.840.1.113762.1.4.1029.335): Added 7 ICD-10-CM codes (N03.A, N04.A, N05.A, N07.A, N18.30, N18.31, N18.32) based on terminology update. Deleted 1 ICD-10-CM code (N18.3) based on terminology update.

    Measure Section: Terminology

    Source of Change: Annual Update

  • Value set Respiratory Support Procedures Related to COVID 19 (2.16.840.1.113762.1.4.1029.379): Deleted 1 ICD-10-PCS code (5A0522C) based on terminology update.

    Measure Section: Terminology

    Source of Change: Annual Update

  • Value set Severe Maternal Morbidity Diagnoses (2.16.840.1.113762.1.4.1029.255): Added 44 ICD-10-CM codes based on terminology update. Deleted 1 ICD-10-CM code (O72.3) based on review by technical experts, SMEs, and/or public feedback. Deleted 8 ICD-10-CM codes (I71.1, I71.5, I63.8, I71.01, I71.2, I71.3, I71.4, I71.6) based on terminology update.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Severe Maternal Morbidity Procedures (2.16.840.1.113762.1.4.1029.256): Added 61 SNOMED CT codes based on review by technical experts, SMEs, and/or public feedback.

    Measure Section: Terminology

    Source of Change: Measure Lead

  • Value set Substance Abuse (2.16.840.1.113762.1.4.1029.320): Added 21 ICD-10-CM codes based on terminology update.

    Measure Section: Terminology

    Source of Change: Annual Update

  • Value set (2.16.840.1.113762.1.4.1029.363): Renamed to Venous Thromboembolism in Pregnancy based on recommended value set naming conventions.

    Measure Section: Terminology

    Source of Change: Annual Update

  • Value set White blood cells count lab test (2.16.840.1.113762.1.4.1045.129): Added 2 LOINC codes (12227-5, 92635-2) based on review by technical experts, SMEs, and/or public feedback.

    Measure Section: Terminology

    Source of Change: Measure Lead

Last Updated: Jun 03, 2024